Horáková, Dana
476  Ergebnisse:
Personensuche X
?
2

Long-term clinical outcomes in patients with multiple scler..:

Butzkueven, Helmut ; Kalincik, Tomas ; Patti, Francesco...
Therapeutic Advances in Neurological Disorders.  17 (2024)  - p. , 2024
 
?
3

Quantitative brain morphometry identifies cerebellar, corti..:

Nestrasil, Igor ; Majovska, Jitka ; Ahmed, Alia...
Molecular Genetics and Metabolism.  141 (2024)  2 - p. 107981 , 2024
 
?
5

Disease-modifying therapies in managing disability worsenin..:

Sharmin, Sifat ; Roos, Izanne ; Malpas, Charles B...
The Lancet Child & Adolescent Health.  8 (2024)  5 - p. 348-357 , 2024
 
?
8

CSF Markers of Oxidative Stress Are Associated with Brain A..:

Burgetova, Andrea ; Dusek, Petr ; Uher, Tomas...
International Journal of Molecular Sciences.  24 (2023)  12 - p. 10048 , 2023
 
?
9

Lexical and syntactic deficits analyzed via automated natur..:

Šubert, Martin ; Novotný, Michal ; Tykalová, Tereza...
Therapeutic Advances in Neurological Disorders.  16 (2023)  - p. , 2023
 
?
10

Proportion and characteristics of secondary progressive mul..:

Forsberg, Lars ; Spelman, Tim ; Klyve, Pernilla...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  9 (2023)  1 - p. 205521732311535 , 2023
 
?
11

Does initial high efficacy therapy in multiple sclerosis su..:

Hrnciarova, Tereza ; Drahota, Jiri ; Spelman, Tim...
Multiple Sclerosis and Related Disorders.  76 (2023)  - p. 104803 , 2023
 
?
 
?
15

Switching to natalizumab or fingolimod in multiple sclerosi..:

Spelman, Tim ; Horakova, Dana ; Ozakbas, Serkan...
Multiple Sclerosis and Related Disorders.  70 (2023)  - p. 104477 , 2023
 
1-15